0QNA - Ticker AI Digest

Basilea Pharmaceutica AG 📰 1
TradingFloor AI GO VIP Login

Digested News

Today's Catalysts (0QNA) 1
0QNA 05:01
Basilea Pharmaceutica AG
Basilea announces a conversion price of CHF 62.50 for its New Bonds and the acceptance of tendered Bonds in an aggregated principal amount of approximately CHF 47 million
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 1
0QNA 17:01
Basilea Pharmaceutica AG
Basilea enters into sale and leaseback agreement for corporate headquarters building
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 0
No items for this category on selected date.
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 1
0QNA 05:16
Basilea Pharmaceutica AG
Basilea launches the placement of CHF 100 million senior convertible bonds with an increase option of CHF 25 million
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 3
0QNA 17:09
Basilea Pharmaceutica AG
Basilea continues with the implementation of the Repurchase Offer and the issuance of New Bonds
0QNA 05:01
Basilea Pharmaceutica AG
Basilea announces the start of the offer period of its partial repurchase offer for its outstanding convertible bonds due 2022
0QNA 05:01
Basilea Pharmaceutica AG
Basilea announces partial repurchase offer for at least CHF 90 million and up to CHF 110 million in principal amount of its outstanding convertible bonds due 2022
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 1
0QNA 05:16
Basilea Pharmaceutica AG
Basilea reports the launch of antifungal Cresemba® (isavuconazole) in Taiwan, triggering the second milestone payment related to Asia-Pacific
Results 0
No items for this category on selected date.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 0
No items for this category on selected date.
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 0
No items for this category on selected date.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 12
0QNA 05:01
Basilea Pharmaceutica AG
Basilea announces a conversion price of CHF 62.50 for its New Bonds and the acceptance of tendered Bonds in an aggregated principal amount of approximately CHF 47 million
0QNA 05:16
Basilea Pharmaceutica AG
Basilea announces completion of patient enrolment into first cohort of phase 2 study FIDES-01 with derazantinib in bile duct cancer (iCCA)
0QNA 17:09
Basilea Pharmaceutica AG
Basilea continues with the implementation of the Repurchase Offer and the issuance of New Bonds
0QNA 05:01
Basilea Pharmaceutica AG
Basilea Bonds tendered in an aggregate principal amount of approximately CHF 47 million
0QNA 05:16
Basilea Pharmaceutica AG
Basilea reports the launch of antifungal Cresemba® (isavuconazole) in Taiwan, triggering the second milestone payment related to Asia-Pacific
0QNA 05:01
Basilea Pharmaceutica AG
Basilea announces the start of the offer period of its partial repurchase offer for its outstanding convertible bonds due 2022
0QNA 05:16
Basilea Pharmaceutica AG
Basilea announces move of corporate headquarters to Allschwil, canton of Basel-Landschaft, in 2022
0QNA 05:01
Basilea Pharmaceutica AG
Basilea announces partial repurchase offer for at least CHF 90 million and up to CHF 110 million in principal amount of its outstanding convertible bonds due 2022
0QNA 18:37
Basilea Pharmaceutica AG
Basilea successfully places CHF 125 million senior convertible bonds
0QNA 05:16
Basilea Pharmaceutica AG
Basilea launches the placement of CHF 100 million senior convertible bonds with an increase option of CHF 25 million
0QNA 17:01
Basilea Pharmaceutica AG
Basilea enters into sale and leaseback agreement for corporate headquarters building
0QNA 05:16
Basilea Pharmaceutica AG
Basilea receives CHF 5 million milestone payment related to marketing authorization of antifungal Cresemba® in Russia

AI Crunch

Single-Ticker AI Crunch
0QNA signal theatre built from scored market catalysts, automated AI forecasts, and live trigger logic.

This is the ticker-specific AI Crunch desk for Basilea Pharmaceutica AG. It compresses bullish and bearish catalyst scoring, best and worst AI forecast paths, and automated buy or sell trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI Forecast Stack Buy / Sell Trigger Engine Catalyst Ledger
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full 0QNA AI Crunch cockpit.

Subscription turns this tab into a live signal desk with bullish vs bearish machine scoring, AI forecast stack comparisons, buy and sell trigger logic, and the full catalyst ledger behind every scored catalyst row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific signal stack, sentiment gauges, forecast stage, and the full catalyst ledger for 0QNA on 2020-07-21.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
4062397
Enterprise Value
582155648
Public Float
107.02
Broker Target
-
Shares Out
10869600
Long Interest
100
Short Interest
-
Exchange
LSE
Currency Code
GBP
ISIN
None
Market
None
Sector
Pharmaceuticals and Biotechnology
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
-
Ex Divi
2009-01-01
Earnings Date
2026-02-17
Net Debt
116117000.0
Cash
12489000.0
EPS
-0.585
Net Income
10451000.0
Revenue
157634000.0
Enterprise Value
582155648
Trailing PE
-
Forward PE
-
Price Sales TTM
-
Price Book MRQ
-
EV Revenue
-
EV EBITDA
-

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
10869600
Public Hands
107.02
Institutions
-
Institutions As Of
-
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
0
Sale Director Dealing
0
Purchase TR1
0
Sale TR1
0
Broker Coverage Rows
0
Institution Holders Tracked
0
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

Today's Catalysts

1 live catalyst just hit 0QNA.

The headlines landing in Digested News are now framed here as today's catalyst tape. Scroll the tab rail to Digested News or jump there instantly below.
Live Tape Data 2020-07-21 AI Charts Landing View
Scroll the tab rail to Digested News any time, or use the jump button to land straight on today's tape.
1 Today
Catalyst Pulse
Basilea Pharmaceutica AG has fresh news flow feeding the chart narrative.
05:01 Today's Catalyst Basilea announces a conversion price of CHF 62.50 for its New Bonds and the acceptance of tendered Bonds in an aggregated principal amount of approximately CHF 47 million
AI Charts Studio
0QNA Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2020-07-21 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
TradingFloor AI Member Login
Indicators0
Technicals0
RSI Gauge
Price Change
AI Forecast
No price history data for 0QNA in selected range.